The influence of nisoldipine--a "calcium entry blocker" on drug induced stereotyped behavior in rats
- PMID: 6684313
- DOI: 10.1016/0278-5846(83)90103-3
The influence of nisoldipine--a "calcium entry blocker" on drug induced stereotyped behavior in rats
Abstract
In view of potential ability of calcium entry blockers to affect Ca2+ fluxes in neurons, the effects of nisoldipine on phencyclidine (PCP) and apomorphine (APO) induced stereotyped behavior have been examined in 3 and 4 week old rats. The rats (3 and 4 weeks old) were pretreated with either 0.2 ml of saline + ethanol mixture (10:1 v/v) or nisoldipine (25 mg/kg) i.p., 5 min before the i.p. administration of PCP (5 mg/kg) or APO (10 mg/kg). While nisoldipine pretreatment significantly blocked the PCP induced stereotypy in 3 and 4 week old rats, the APO induced stereotypy was not altered. These preliminary data suggest that nisoldipine specifically blocks PCP induced stereotypy probably by antagonizing it effects at the presynaptic level. The significance of this finding in relation to mechanism of action of PCP and calcium entry blockers is discussed.
Similar articles
-
Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.Psychopharmacology (Berl). 1981;75(1):44-7. doi: 10.1007/BF00433500. Psychopharmacology (Berl). 1981. PMID: 6795658
-
Differential involvement of voltage-dependent calcium channels in apomorphine-induced hypermotility and stereotypy.Psychopharmacology (Berl). 1994 Jan;113(3-4):555-60. doi: 10.1007/BF02245239. Psychopharmacology (Berl). 1994. PMID: 7862875
-
Influence of non-L-type calcium channel antagonists on phencyclidine-induced effects in rats.Life Sci. 1993;52(25):2055-61. doi: 10.1016/0024-3205(93)90690-5. Life Sci. 1993. PMID: 8502132
-
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.Microcirc Endothelium Lymphatics. 1984 Apr;1(2):185-220. Microcirc Endothelium Lymphatics. 1984. PMID: 6400430 Review.
-
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.Drugs. 1988 Dec;36(6):682-731. doi: 10.2165/00003495-198836060-00003. Drugs. 1988. PMID: 3065058 Review.
Cited by
-
Psychopharmacological properties of calcium channel inhibitors.Psychopharmacology (Berl). 1992;109(1-2):12-29. doi: 10.1007/BF02245476. Psychopharmacology (Berl). 1992. PMID: 1365644 Review.
-
Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain.J Neural Transm. 1989;75(3):195-200. doi: 10.1007/BF01258630. J Neural Transm. 1989. PMID: 2926382
-
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.Sci Adv. 2019 May 8;5(5):eaau9093. doi: 10.1126/sciadv.aau9093. eCollection 2019 May. Sci Adv. 2019. PMID: 31086815 Free PMC article.
-
Some central pharmacological effects of the calcium channel antagonist flunarizine.J Neural Transm Gen Sect. 1991;83(3):179-88. doi: 10.1007/BF01253388. J Neural Transm Gen Sect. 1991. PMID: 2031709
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous